Health Evaluation in African Americans Using RAS Therapy
Status:
Recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Telmisartan, an FDA approved blood pressure
medication, may also have beneficial effects on Alzheimer's disease prevention in African
Americans, who are at high risk for Alzheimer's disease.